< Back to scientific publications

Magazine 3.52

MicroRNAs modulation and clinical outcomes at 1 year of follow-up in obese patients with pre-diabetes treated with metformin vs. placebo.

Authors: Sardu C, Trotta MC, Pieretti G, Gatta G, Ferraro G, Nicoletti GF, D' Onofrio N, Balestrieri ML, D' Amico M, Abbatecola A, Ferraraccio F, Panarese I, Paolisso G, Marfella R.

Date: 2021

Scope of interest: diabetes




You may also be interested in:

Report/Poster of Convention/Congress Act

“Communicable Infections and Hospital-Territory Integration”

Authors: ilaria uccella

Date: 2019

Scope of interest: infectious disease training programs


Read details
Magazine

Use of Plerixafor in Predicted and ProvenPoorMobilizer( according to GITMO criteria). Experience of Tor Vergata University Polyclinic.

Authors: Massimiliano Postorino, Alessandro Lanti, Eleonora Florelli, Angelo Salvatore Ferraro, Oana Marilena Chiuru,Raffaella Massarelli, Luca Franceschini, Giorgia Guiducci,Provenzano I., Livio Pupo, Anna Giulia Zizzari, GaspareAdorno, Maria Cantonetti, Giancarlo Isacchi and Sergio Amadori. (2012).

Date: 2012

Scope of interest: Hematology/Transfusion Medicine


Read details
Magazine 7.32

Late-onset seizures and epilepsy: Electroclinical features suggestive of autoimmune etiology

Authors: Morano A, Cerulli Irelli E, Salamone EM, Orlando B, Fanella M, Tinelli E, Ruffolo G, Zuliani L, Fattouch J, Manfredi M, Giallonardo AT, Di Bonaventura C.

Date: 2022

Scope of interest: Epilepsy/autoimmune diseases of the CNS


Read details